![](/images/graphics-bg.png)
Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds
المؤلفون المشاركون
Bonamonte, Domenico
Vestita, Michelangelo
Filoni, Angela
Giudice, Giuseppe
Maggio, Giulio
المصدر
العدد
المجلد 2017، العدد 2017 (31 ديسمبر/كانون الأول 2017)، ص ص. 1-5، 5ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2017-02-15
دولة النشر
مصر
عدد الصفحات
5
التخصصات الرئيسية
الملخص EN
Introduction.
Given its efficacy and safety, NexoBrid™ (NXB) has become part of our therapeutic options in burns treatment with satisfactory results.
However, no cost analysis comparing NXB to the standard of care (SOC) has been carried out as of today.
Aim.
To assess the cost of treatment with NXB and compare it to the SOC cost.
Methods.
20 patients with 14–22% of TBSA with an intermediate-deep thermal burn related injury were retrospectively and consecutively included.
10 of these patients were treated with the SOC, while the other 10 with NXB.
The cost analysis was performed in accordance with the weighted average Italian Health Ministry DRGs and with Conferenza Stato/Regioni 2003 and the study by Tan et al.
For each cost, 95% confidence intervals have been evaluated.
Results.
Considering the 10 patients treated with NXB, the overall savings (total net saving) amounted to 53300 euros.
The confidence interval analysis confirmed the savings.
Discussion.
As shown by our preliminary results, significant savings are obtained with the use of NXB.
The limit of our study is that it is based on Italian health care costs and assesses a relative small cohort of patients.
Further studies on larger multinational cohorts are warranted.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Giudice, Giuseppe& Filoni, Angela& Maggio, Giulio& Bonamonte, Domenico& Vestita, Michelangelo. 2017. Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds. BioMed Research International،Vol. 2017, no. 2017, pp.1-5.
https://search.emarefa.net/detail/BIM-1139607
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Giudice, Giuseppe…[et al.]. Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds. BioMed Research International No. 2017 (2017), pp.1-5.
https://search.emarefa.net/detail/BIM-1139607
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Giudice, Giuseppe& Filoni, Angela& Maggio, Giulio& Bonamonte, Domenico& Vestita, Michelangelo. Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-5.
https://search.emarefa.net/detail/BIM-1139607
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1139607
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)